🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and safety of NXC-201...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2027-01
Trial ID
NCT07709715
Treatments Being Tested
This is an open-label, multicenter, Phase 2 study in subjects with newly di...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2024-06-15
Trial ID
NCT06418477
Treatments Being Tested
Before effective treatment, the prognosis of patients with AL amyloidosis i...
Status
Not Yet Recruiting
Location
Peking University First Hospital
Start Date
2025-10
Trial ID
NCT07215494
Treatments Being Tested
The purpose of this study is to evaluate complete response plus (+) very go...
Status
Completed
Location
Multiple Locations
Start Date
2016-11-09
Trial ID
NCT02951819
Treatments Being Tested
This is an open-label, multicenter, phase 2 study in subjects with newly di...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-01-15
Trial ID
NCT06771180
Treatments Being Tested
This study is a Phase Ib open label, single arm, adaptive multicentre trial...
Status
Unknown
Location
Galway University Hospital
Start Date
2016-11
Trial ID
NCT02955810
Treatments Being Tested
This is a multicenter, open-label, phase 1, single arm study intended to de...
Status
Completed
Location
Local Institution - 119
Start Date
2020-05-27
Trial ID
NCT04196491
Treatments Being Tested
The goal of this study is to assess the efficacy of induction treatment wit...
Status
Recruiting
Location
Georgia Cancer Center-Augusta University
Start Date
2024-11-01
Trial ID
NCT06142396
The purpose of this study is to find out whether cyclophosphamide, bortezom...
Status
Recruiting
Location
Tufts Medical Center (Data Collection Only)
Start Date
2023-10-16
Trial ID
NCT06083922
Treatments Being Tested
Amyloid light chain (AL) amyloidosis is a rare disease caused by abnormal p...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-11-29
Trial ID
NCT07793422